Accelerated 15 mW pulsed-light crosslinking to treat progressive keratoconus: Two-year clinical results
- 1 August 2017
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Cataract & Refractive Surgery
- Vol. 43 (8), 1081-1088
- https://doi.org/10.1016/j.jcrs.2017.05.030
Abstract
Purpose To assess the clinical and microstructural results of accelerated 15 mW pulsed-light corneal crosslinking (CXL) to treat progressive keratoconus. Setting Siena Crosslinking Center, Siena, Italy. Design Prospective case series. Methods After epithelium removal (with Epi-Clear) and 10 minutes stromal soaking with riboflavin 0.1% hydroxypropyl methylcellulose solution, all eyes had 15 mW/cm2 pulsed-light epithelium-off accelerated CXL for 6 minutes of ultraviolet-A (UVA) irradiation (1 second on/1 second off), maintaining a total UVA exposure of 12 minutes at a fluence of 5.4 J/cm2. The 2-year follow-up examination included uncorrected (UDVA) and corrected (CDVA) distance visual acuities, Scheimpflug tomography, in vivo confocal microscopy (IVCM), and spectral-domain optical coherence tomography (SD-OCT). Results The study comprised 132 eyes of 96 patients (mean age 23.7 years ± 4.3 [SD]) with stage II keratoconus. The change in UDVA and CDVA was statistically significant, from 0.51 ± 0.106 logarithm of the minimum angle of resolution (logMAR) at baseline to 0.309 ± 0.074 logMAR (P = .0001) and 0.271 ± 0.144 logMAR at baseline to 0.135 ± 0.100 logMAR (P = .0023), respectively. Coma values measured by Scheimpflug analysis showed a statistically significant improvement beginning with the first postoperative month (P = .0004). The IVCM scans documented basal epithelial healing occurring 72 hours after treatment associated with the presence of subepithelial nerves. The SD-OCT scans performed in the central 6.0 mm of corneal diameter documented a demarcation line at a mean depth of 280 ± 32 μm. Conclusion The 15 mW/cm2 pulsed-light epithelium-off accelerated CXL was effective and safe, stabilizing keratoconus progression through 2 years of follow-up.Keywords
This publication has 21 references indexed in Scilit:
- Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus in Pediatric PatientsEuropean Journal of Ophthalmology, 2016
- Nationwide reduction in the number of corneal transplantations for keratoconus following the implementation of cross‐linkingActa Ophthalmologica, 2016
- Corneal Cross-linking to Halt the Progression of Keratoconus and Corneal Ectasia: Seven-Year Follow-upAmerican Journal of Ophthalmology, 2015
- Accelerated Corneal Collagen Cross-linking for Postoperative LASIK Ectasia: Two-Year OutcomesJournal of Refractive Surgery, 2015
- Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: Ten-year resultsJournal of Cataract & Refractive Surgery, 2015
- Accelerated Photoactivated Chromophore for Keratitis–Corneal Collagen Cross-linking as a First-line and Sole Treatment in Early Fungal KeratitisJournal of Refractive Surgery, 2014
- Accelerated (9-mW/cm2) Corneal Collagen Crosslinking for Keratoconus—A 1-Year Follow-upCornea, 2014
- Long-term Results of Riboflavin Ultraviolet A Corneal Collagen Cross-linking for Keratoconus in Italy: The Siena Eye Cross StudyAmerican Journal of Ophthalmology, 2010
- Ultraviolet A/Riboflavin Corneal Cross-linking for Infectious Keratitis Associated With Corneal MeltsCornea, 2008
- Safety of UVA-Riboflavin Cross-Linking of the CorneaCornea, 2007